Top 6 Afib Studies in 2017: Part I

Cardiologist and Patient Care author Payal Kohli, MD offers snap shots of 6 influential studies that will affect the future of AF diagnosis and treatment.

2017 was a roller-coaster year in cardiology research with trials such as the CAD sham-controlled ORBITA trial turning our beliefs about revascularization upside down and the new ACC/AHA hypertension guidelines generating controversy from the community given the far-reaching implications suggested. As a sampling, here is Part 1 of my top 6 study picks in the world of atrial fibrillation that I reviewed on Patient Care during 2017 and why I think they are important.For Part II, please click here. 

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.